Outrun Therapeutics
PrivateLast Round
Seed
Apr 18, 2024
Total Funding Raised
$10M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Outrun Therapeutics is a biotechnology company that develops small molecule inhibitors targeting E3 ligases for protein stabilization to treat diseases, with a lead program focused on hard-to-treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Outrun Therapeutics Comparables
Compare Outrun Therapeutics with similar companies based on industry and business-model similarity.
Outrun Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 18, 2024 |
Outrun Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Healthcare Venture Management | Seed |
| M Ventures | Seed |
| M Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 192% MoM, reaching 1.4K.
- Mar 17, 2026
Lead programme targets HPV positive head and neck cancer.
Outrun Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Outrun Therapeutics's valuation, stock price, and market status.
Is Outrun Therapeutics a public or private company?
Outrun Therapeutics is a private company.
What is the current stock price of Outrun Therapeutics?
Outrun Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Outrun Therapeutics worth (valuation)?
Valuation information for Outrun Therapeutics is not publicly available.
Can I buy Outrun Therapeutics stock?
Outrun Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Outrun Therapeutics's last funding round?
Outrun Therapeutics's most recent funding round was Seed on April 18, 2024.
Who are the main investors in Outrun Therapeutics?
Key investors in Outrun Therapeutics include MP Healthcare Venture Management, M Ventures.
Will Outrun Therapeutics IPO soon?
No public IPO plans have been announced for Outrun Therapeutics.
How can I track Outrun Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Outrun Therapeutics's secondary market activity and sign up for updates.